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he effect of Microcurrent Electrical Nerve Stimulation (MENS) was evaluated and compared with occlusal splint therapy in
temporomandibular disorders (TMD) patients with muscle pain. Twenty TMD patients were divided into four groups. One
received occlusal splint therapy and MENS (I); other received splints and placebo MENS (II); the third, only MENS (III) and
the last group, placebo MENS (IV). Sensitivity derived from muscle palpation was evaluated using a visual analogue scale.
Results were submitted to analysis of variance (p<0.05). There was reduction of pain level in all groups: group I (occlusal splint
and MENS) had a 47.7% reduction rate; group II (occlusal splint and placebo MENS), 66.7%; group III (MENS), 49.7% and
group IV (placebo MENS), 16.5%. In spite of that, there was no statistical difference (analysis of variance / p<0.05) between
MENS and occlusal splint therapy regarding muscle pain reduction in TMD patients after four weeks.
Uniterms: Temporomandibular joint disorders; Occlusal splints; Electric stimulation therapy.
   efetividade da Estimulação Neural Elétrica por Microcorrente (MENS) foi avaliada e comparada à terapia por Placas
Oclusais em pacientes com desordens temporomandibulares (DTM) de origem muscular. Vinte pacientes foram divididos em
quatro grupos. Um recebeu a terapia por placas interoclusais e MENS (I); outro, placas e MENS placebo (II), o terceiro,
somente MENS (III) e o último grupo, MENS placebo (IV). Os resultados obtidos foram submetidos a uma análise de variância
(p<0,05). Houve redução dos níveis de dor em todos os grupos: o grupo I (placas e MENS) obteve uma taxa de redução de
47,7%; o grupo II (placa e MENS placebo), 66,7%; o grupo III (MENS), 49,7% e o grupo IV (MENS placebo), 16,5%. Apesar
disso, não se verificaram diferenças estatisticamente significantes entre MENS e utilização de placas interoclusais em relação
à diminuição de dor muscular em pacientes com DTMs após 4 semanas.
Unitermos: Transtornos da articulação temporomandibular; Placas oclusais; Terapia por estimulação elétrica.
INTRODUCTION
Headache, earache, muscle and TMJ pain are considered
consequences of muscle hyperactivity or alteration in
occlusal vertical dimension4,7,25. Headache may be associated
to macrotrauma, unilateral chewing and bruxism8. Moreover,
it is also related to problems in muscle physiology as in
occlusal interferences and tensional discharge23.
Nervous system control, normal rhythmic contraction
and relaxation of muscles depend on the availability of
nutrients from arterial blood and removal of metabolites by
venous blood. Intramuscular pressure during contraction
can exceed the blood pressure and stop arterial flow1. In
muscles that are isometrically contracted for a prolonged
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period of time (chewing or bruxism) there is interference
with normal blood circulation and therefore interference with
ionic interchange at the cells membranes; increase of pyruvic
and lactic acid; glycogen depletion; oxygen debt; and
decrease of metabolites clearance1,23,27.
Epidemiological studies about Temporomandibular
Disorders (TMD) signs and symptoms in young subjects
indicated that 48% of them present muscle sensitivity and
the frequency was higher in females22.
Muscle pain reduction may be obtained by physical
therapy, drugs, psychotherapy and occlusal therapy.
Physical therapy aims at muscle relaxation and increase of
lymphatic and blood circulation to reestablish the muscle
physiology20.
Electricity can be used as physical therapy to reduce
muscle pain. The earliest written records of using it come
from the Greeks3. Transcutaneous electrical nerve
stimulation (TENS) is one type of physical therapy employed
to TMD treatment. The use of TENS is based on several
interrelated theories on the mechanisms of pain transmission
and blocking of those mechanisms3. The first of these
theories was the gate control theory and it was introduced
by Melzack and Wall in 1965.17 This theory suggests that
stimulation of thick, myelinated, sensory fibers (A-fibers)
blocks the impulses of thin pain-modulating fibers (C-fibers)
and closes the gate to pain signals at their level of entry into
spinal cord17.
Another theory is related to endogenous release of
morphine-like substances after electrical stimulation. These
substances would have analgesic properties18.
A third way of action of TENS is related to automatic
and involuntary contraction of muscles. Repetitive
depolarizations of skeletal muscle at a rate less than 100/min
in the presence of an adequate supply of high-energy
phosphate reduces fatigue contracture26. Mild, rhythmic
muscle movement increases the local circulation of blood
and lymph, which reduces the interstitial edema and
accumulation of noxious tissue metabolites13,26,27.
Wessberg, et al.26 evaluated the clinical effectiveness of
a neuromuscular approach including TENS to the
management of 21 myofascial pain-dysfunction syndrome
subjects. The subjects complained of having had facial pain
symptoms for up to 1 year. Results showed 95% success
immediately after therapy and an 86% success one year
after therapy. The authors suggest that discrepancies in the
transverse and anteroposterior position of the mandible
relative to centric occlusion are not well tolerated. Elimination
of pain through TENS and adjustment or occlusal splint
therapy seems to promote the long-term relief of muscle
symptoms.
TENS effects on temporalis muscles, masseter muscles
and digastric muscles electromyography was studied by
Cooper10. This author observed an electrical activity
decrease of these muscles of about 36.7% in rest position
after TENS application. On the other hand, there was an
increase of about 89.8% and 53.6% in masseter and
temporalis muscles, respectively, during clenching.
Møystad, et al.18 evaluated and compared the effect of
TENS with placebo TENS in 19 patients with orofacial
functional pain and rheumatic disease involving the
temporomandibular joint. Pain was measured using a Visual
Analogue Scale (VAS). Results demonstrated that TENS
and placebo treatment were effective.
TENS stimulus are in order of milliamps (sensorial and
motor stimulus). It produces a maximum metabolic effect on
protein synthesis and benefits the cell physiology6,18.
Besides TENS, an alternative method of pain control,
which has received little attention in dentistry, is the
microcurrent electrical nerve stimulation (MENS). It
provides currents lower than 1000 microamps (µA). They
are considered microcurrent units and do not stimulate motor
fibers11. Byl, et al.5 stated that many clinicians are using
microamperage stimulation to relieve pain and facilitate
wound healing. This author studied the microamperage
stimulation effects for soft tissue wound repair. There was
no wound healing acceleration, however no negative effects
were found.
Lambert, et al.14 evaluated MENS effects on symptoms
of muscle damage. The muscles of non-dominant arms of
thirty healthy men were damaged using an eccentric-exercise
protocol. Fifteen received electro-membrane microcurrent
therapy (membranes which provide electric stimulation) and
the other fifteen received placebo membrane. The membranes
were well tolerated by subjects in both groups without any
adverse effects. Electro-membrane microcurrent therapy
reduced the severity of damage symptoms but did not alter
pain perception or arm swelling. According to the authors14,
the microcurrent mechanisms of action are unknown but are
likely related to maintenance of intracellular Ca2+
homeostasis after muscle damage. Increasing in intracellular
calcium concentration may influence changes in membrane
integrity and/or cause morphological alterations in the
contractile machinery of muscle reducing its function26.
In TMD treatments, Dupont11 presented a MENS protocol
to localization and treatment of trigger points. This author
suggested that microcurrent is an effective modality for
identifying and treating myofascial and temporomandibular
disorders. MENS is accomplished with probes individually
or in combination with pads. The probes are used to treat
small areas, individual muscles and for very short-time
treatments. Pads can be used for longer treatment times and
larger areas11.
Bertolucci and Grey2 (1995) performed treatment in TMD
patients, comparing the effect of MENS, Mid Laser and
Placebo treatment, for three weeks, verifying the efficacy of
the MENS and Laser therapies on alleviation of pain with
subsequent enhancement of joint mobility.
Unfortunately, there is a lack of scientific researches
using MENS to TMD treatment or comparing its effects, if
any, with other treatment methods.
The purpose of this study was to compare the
effectiveness of microcurrent electrical nerve stimulation
(MENS) and occlusal splint therapy on masticatory muscles
pain in TMD patients.
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MATERIALS AND METHODS
Subject Selection
This study was in accordance with the ethical standards
of the committee on human experimentation (Process
number: 2003-00556).
For the study, twenty TMD patients, 2 men and 18
women, aged 13 to 47 years old, were selected from patients
who came for treatment at the Temporomandibular Disorders
Diagnostic and Treatment Center.
The criteria used for subject selection included: muscle
pain could be elicited by palpation and verified over six
months, chronic pain; there was no more than one missing
tooth per quadrant; and no patient was wearing any
removable restorations. Patients meeting these requirements
were asked to participate in the research project. The criteria
used for subject exclusion were in accordance with
microcurrent contraindications. The following areas or
conditions are contraindicated: conditions with unknown
etiology; conditions which demand cardiac pacemakers;
areas over cancer lesions or the carotid sinus and the
transcerebral area. Safety has not been established for use
in cases of pregnancy, seizures or heart patients, pain of
central origin, epilepsy, or with some skin and vascular
disorders11. Patients with articular involving were also
excluded.
Groups and Therapies
The patients were divided into four groups. Microcurrent
therapy was effectively accomplished in two groups. One
received occlusal splint therapy and the other received only
MENS. In two other groups, a MENS therapy simulation
(placebo) was performed with the apparatus turned off18. In
the same way, one group received occlusal splint therapy
and the other only placebo treatment. Thereby, the patients
were randomly placed in one of four treatment modalities:
group I (occlusal splint therapy and MENS), group II
(occlusal splint therapy and placebo MENS), group III
(MENS) or group IV (placebo MENS).
For this study the authors used a microcurrent stimulator
apparatus (Model Micro Master S-10 / Bio Therapeutic
Computers Inc., Hong Kong) for MENS therapy. The
frequency was set at 0.3 Hz and the amplitude at 40 µA11.
The applications were performed twice a week during four
weeks, adding up to eight applications of ten minutes each.
Microcurrent applications on affected muscles were made
using conductive pads or probes. When the access was
extraoral, conductive gel and pads were used. Before
application, the treatment area was washed with water and
soap and cleaned with alcohol to remove the skin oils. On
the other hand, when the access was intraoral, the
application was performed using wet probes with salt water11.
Maxillary and mandibular alginate impressions were taken
for groups I and II subject for fabrication of maxillary
occlusal splint. Impressions were poured using special
gypsum type IV (Durone, Dentsply) and the casts were
mounted in semi-adjustable articulator. Occlusal splints were
fabricated from heat cured acrylic resin. The occlusal splints
provided even, simultaneous, bilateral, multiple posterior
contacts. Adequate canine guidance was provided to
disarticulate all posterior teeth during eccentric movement.
Each patient was evaluated at weekly intervals for necessary
adjustments of the splint.
In group II and IV, the placebo MENS therapy was
performed through simulation of application. Conductive
pads or probes were positioned on the affected muscle area,
but with the apparatus turned off. Subjects did not detect it
because the microcurrent stimulus is subsensorial.
Record of Pain Levels
On entering the research project, a history of symptoms
and clinical examinations was achieved. The clinical
examination was completed on each patient to determine
the degree of pain or tenderness by palpation. A digital
pressure of about 2 Kgf was used for palpation of affected
muscles. The evaluation method in the present study was
based on subjective measurement. Pain measurements were
made using a 0 to 10 Visual Analogue Scale. The patients
were asked to record their pain on the 10 cm VAS line between
the two extremes: zero was no pain and 10, the highest (ever
perceived) possible pain16,18.
Muscle tenderness to palpation was evaluated before
and after treatment by the same operator. In this way, therapy
effect on muscle symptoms was verified in each group.
Final evaluation was made after four weeks of treatment.
Results were obtained through the mean of pain reduction
of five subjects of each group.
RESULTS
The data collected for subjects in the four groups are
summarized in Tables 1, 2, 3 and 4.
Group I, composed of subjects treated by occlusal splint
therapy and microcurrent electrical stimulation,
demonstrated a 47.7% pain level reduction rate. In group II,
composed of subjects in whom occlusal splints were installed
and MENS was applied through the apparatus turned off
(placebo), a 66.9% pain reduction rate was observed. In
group III, for whom only MENS was applied, this rate was
49.7%. In group IV treated by placebo, there was the smallest
pain reduction rate. In this group, we could note decrease in
muscle symptoms in three subjects. One subject did not
show difference before and after the study. Nevertheless, in
one patient, there was an increase in pain originated from
muscle palpation. The mean found in reduction of muscle
pain was 16.5%.
Pain reduction rate was calculated to each subject
comparing the initial and final situation. The data collected
were used in statistical test (analysis of variance / p<0.05).
There were no statistical differences between the four groups
or between occlusal splints and microcurrent.
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DISCUSSION
The use of MENS in dentistry has received only limited
attention. There is not enough research about MENS use in
temporomandibular disorder treatment to make an adequate
evaluation. This study appraised and compared MENS and
the occlusal splint effectiveness on muscle pain in TMD
patients.
Objective measures are often the basis for conclusions
in treatment evaluation. The pain evaluation relies on the
subjective judgment of the patient, because “objective pain”
does not exist18. Pain is an extremely personal experience.
Different individuals submitted to identical stimulus feel
several ways of pain and react with different suffering levels.
Patients feeling a little pain can suffer a lot, while others
with a significant pain can suffer less. The more severe the
symptom and the more the patient is affected, the more
emotional will be their answers and the larger the impact on
his or her functional capacity15. Pain intensity by physical
lesions is related to given attention at the moment. Clinicians
have a mission to collect patient information and to be able
to interpret the symptoms characteristics and their
significance to the patient19.
Pain can be important since the lesion consequences
induce concern and anxiety feelings related more to
treatment and repair processes than to the hurt24. Anxious
GROUP I PAT 1 PAT 2 PAT 3 PAT 4 PAT 5
MENS and
Oclusal Splint
Initial Appointment 6.7 4 6.3 4.5 8
Final Appointment 0 4 3 4.0 2
Pain Reduction AVERAGE 100 0 52.4 11.1 75
Rate (%) 47.7
TABLE 1- Pain level of patients before and after treatment in group I (MENS and Occlusal Splint) using a Visual Analogue
Scale
GROUP II PAT 1 PAT 2 PAT 3 PAT 4 PAT 5
MENS placebo
and Oclusal Splint
Initial Appointment 8 5.5 7 10 10
Final Appointment 3.5 0 5 2 3
Pain Reduction AVERAGE 56.2 100 28.6 80 70
Rate (%) 66.9
TABLE 2- Pain level of patients before and after treatment in group II (MENS placebo and Occlusal Splint) using a Visual
Analogue Scale
GROUP III PAT 1 PAT 2 PAT 3 PAT 4 PAT 5
MENS
Initial Appointment 3 7.7 8.5 7 7.7
Final Appointment 2 5.3 3 3 2
Pain Reduction AVERAGE 33.3 31.1 64.7 57.1 62.5
Rate (%) 49.7
TABLE 3- Pain level of patients before and after treatment in group III (MENS) using a Visual Analogue Scale
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patients and patients with chronic painful diseases are more
likely to respond positively to placebo therapy. The greater
the need for treatment, the greater the placebo effect18.
Dupont11 recommended palpating for pain levels in the
involved areas and noting it for comparison after treatment.
The patient behavior is the sole way that clinicians have to
receive the painful experience. It is related to their visible
and audible actions. It is important to recognize that the
information is not the nociception, but their painful
behavior19.
Thus, pain quantification is a difficult task and we should
have caution to analyze results of experiments studying
pain phenomenon. Although it is possible to compare pain
processes through the Visual Analogue Scale, the individual
painful behaviors are different19. Quantitative analysis of
symptoms through the analogue scale is an auxiliary
procedure in the clinical approach. Results of this study
serve as an indication about the effectiveness of the different
therapeutic modalities appraised. Therefore, it is difficult to
derive any comparative conclusions regarding the
effectiveness of a given therapy on symptoms21. However,
more studies are necessary about this subject.
In this study, although the symptoms of patients
decreased after the 4-week treatment period, statistical
analysis did not show significant difference between
treatment methods employed. However, groups must be
evaluated with the understanding that pain measurement is
influenced by subjective factors.
It was observed that even in the subjects submitted to
placebo treatment (Group IV), there was 16.5% of reduction
in the muscle pain levels. However, one subject of this group
presented an increase in pain level. The action mechanism
of placebo treatment to pain decrease could be explained
pharmacologically by endogen opioid mechanisms12. Instead
of ignoring psychophysiologic factors, clinicians should
be reminded of their importance. Møystad, et al.18
recommended that clinicians should use the placebo effect
and consider the possible use of this effect in the evaluation
of new treatment modalities before claiming that one
treatment is better than another.
The more expressive results related to decrease of pain
levels were found in group II. In this group, treated by
occlusal splints and without MENS, the reduction in pain
level was 66.9%. In group I that associated MENS and
occlusal splint therapies, the mean was 47.7%. One subject
of this group was indifferent to treatment. This result
suggests that MENS does not improve the occlusal splint
effectiveness. On the other hand, the occlusal splint
effectiveness to decrease the muscle symptoms may be
explained by some manners: proprioception adjustment by
splint and even lessen it to mitigate proprioceptive output;
establishment of “ideal occlusal scheme” (simultaneous,
bilateral and multiple posterior tooth contact with excursive
guidance on the canine and/or anterior teeth), short term
effects of vertical dimension increase, muscle skeletal
stabilization and placebo effect9,12.
In group III (MENS without occlusal splint), there was
also reduction of pain levels in all analyzed subjects (mean
of 49.7%). However, there was no significant difference
between the analyzed groups.
CONCLUSION
According to the results obtained through the
methodology of this study, there was no statistically
significant difference between MENS and occlusal splints
effectiveness on pain reduction of masticatory muscles in
TMD patients, and it was verified that the least decreasing
pain percent occurred when only MENS placebo was
employed.
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